US Stock MarketDetailed Quotes

HURA TuHURA Biosciences

Watchlist

4.480
+0.480+12.00%

Close Dec 20 16:00 ET

4.280
-0.200-4.46%

Post 19:54 ET

189.43MMarket Cap-3.83P/E (TTM)

TuHURA Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Sep 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

41.57%-1.89M

-18.60%-3.83M

-59.17%-11.95M

-74.58%-3.23M

-14.40%-7.51M

-1.85M

-6.56M

Net income from continuing operations

88.45%-2.16M

74.12%-4.84M

-212.96%-29.32M

-778.02%-18.71M

-33.51%-9.37M

---2.13M

---7.02M

Operating gains losses

----

---12.09K

----

27.36%-294.07K

----

---404.85K

Depreciation and amortization

-71.88%17K

-43.24%34.31K

-52.46%177.38K

-35.70%60.45K

-2.00%373.09K

--94.01K

--380.69K

Other non cash items

----

--17.38K

--5.12K

----

--629.29K

Change In working capital

115.93%152K

166.43%633.7K

-68.83%486.92K

-711.09%-953.95K

421.26%1.56M

--156.11K

---486.2K

-Change in prepaid assets

--156K

----

-Change in payables and accrued expense

99.67%-4K

156.86%691.88K

-81.73%337.75K

-984.63%-1.22M

493.01%1.85M

--137.55K

---470.34K

-Change in other current assets

----

-122.13%-58.19K

152.07%149.18K

1,316.83%262.88K

-3,455.35%-286.51K

--18.55K

--8.54K

-Change in other working capital

----

---24.4K

Cash from discontinued investing activities

Operating cash flow

41.57%-1.89M

-18.60%-3.83M

-59.17%-11.95M

-74.58%-3.23M

-14.40%-7.51M

---1.85M

---6.56M

Investing cash flow

Cash flow from continuing investing activities

-3,474.93%-1.3M

-1.2M

-1,006.01%-36.28K

-3.28K

Net PPE purchase and sale

----

-118.39%-79.22K

----

-1,006.01%-36.28K

----

---3.28K

Net business purchase and sale

----

--0

---1.22M

---1.2M

--0

----

Cash from discontinued investing activities

Investing cash flow

----

--0

-3,474.93%-1.3M

---1.2M

-1,006.01%-36.28K

--0

---3.28K

Financing cash flow

Cash flow from continuing financing activities

4.63M

-83.63%2.66M

130.69%16.25M

-150K

7.04M

Net issuance payments of debt

----

--4.9M

867.14%2.69M

--0

-219.02%-350K

---150K

--294.07K

Net common stock issuance

----

---24.75K

----

--0

----

--5.6M

Net preferred stock issuance

----

--0

----

1,342.98%16.6M

----

--1.15M

Cash dividends paid

--0

----

Net other financing activities

----

---272.3K

----

Cash from discontinued financing activities

Financing cash flow

--0

--4.63M

-83.63%2.66M

--0

130.69%16.25M

---150K

--7.04M

Net cash flow

Beginning cash position

-65.56%4.91M

-74.29%3.67M

156.98%14.25M

9.43%5.55M

--5.55M

--5.07M

Current changes in cash

57.39%-1.89M

117.97%796.46K

-221.60%-10.59M

-121.45%-4.43M

1,721.77%8.71M

---2M

--477.91K

End cash Position

-69.25%3.02M

-54.57%4.46M

-74.29%3.67M

177.06%9.82M

156.98%14.25M

--3.54M

--5.55M

Free cash flow

41.57%-1.89M

-18.60%-3.83M

-59.45%-12.03M

-74.58%-3.23M

-14.89%-7.54M

---1.85M

---6.57M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Sep 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	41.57%-1.89M	-18.60%-3.83M	-59.17%-11.95M	-74.58%-3.23M	-14.40%-7.51M	-1.85M	-6.56M
Net income from continuing operations	88.45%-2.16M	74.12%-4.84M	-212.96%-29.32M	-778.02%-18.71M	-33.51%-9.37M	---2.13M	---7.02M
Operating gains losses	----	---12.09K	----	----	27.36%-294.07K	----	---404.85K
Depreciation and amortization	-71.88%17K	-43.24%34.31K	-52.46%177.38K	-35.70%60.45K	-2.00%373.09K	--94.01K	--380.69K
Other non cash items	----	--17.38K	--5.12K	----	----	----	--629.29K
Change In working capital	115.93%152K	166.43%633.7K	-68.83%486.92K	-711.09%-953.95K	421.26%1.56M	--156.11K	---486.2K
-Change in prepaid assets	--156K	----	----	----	----	----	----
-Change in payables and accrued expense	99.67%-4K	156.86%691.88K	-81.73%337.75K	-984.63%-1.22M	493.01%1.85M	--137.55K	---470.34K
-Change in other current assets	----	-122.13%-58.19K	152.07%149.18K	1,316.83%262.88K	-3,455.35%-286.51K	--18.55K	--8.54K
-Change in other working capital	----	----	----	----	----	----	---24.4K
Cash from discontinued investing activities
Operating cash flow	41.57%-1.89M	-18.60%-3.83M	-59.17%-11.95M	-74.58%-3.23M	-14.40%-7.51M	---1.85M	---6.56M
Investing cash flow
Cash flow from continuing investing activities		0	-3,474.93%-1.3M	-1.2M	-1,006.01%-36.28K	0	-3.28K
Net PPE purchase and sale	----	----	-118.39%-79.22K	----	-1,006.01%-36.28K	----	---3.28K
Net business purchase and sale	----	--0	---1.22M	---1.2M	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	----	--0	-3,474.93%-1.3M	---1.2M	-1,006.01%-36.28K	--0	---3.28K
Financing cash flow
Cash flow from continuing financing activities	0	4.63M	-83.63%2.66M	0	130.69%16.25M	-150K	7.04M
Net issuance payments of debt	----	--4.9M	867.14%2.69M	--0	-219.02%-350K	---150K	--294.07K
Net common stock issuance	----	----	---24.75K	----	--0	----	--5.6M
Net preferred stock issuance	----	----	--0	----	1,342.98%16.6M	----	--1.15M
Cash dividends paid	--0	----	----	----	----	----	----
Net other financing activities	----	---272.3K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	--4.63M	-83.63%2.66M	--0	130.69%16.25M	---150K	--7.04M
Net cash flow
Beginning cash position	-65.56%4.91M	-74.29%3.67M	156.98%14.25M	156.98%14.25M	9.43%5.55M	--5.55M	--5.07M
Current changes in cash	57.39%-1.89M	117.97%796.46K	-221.60%-10.59M	-121.45%-4.43M	1,721.77%8.71M	---2M	--477.91K
End cash Position	-69.25%3.02M	-54.57%4.46M	-74.29%3.67M	177.06%9.82M	156.98%14.25M	--3.54M	--5.55M
Free cash flow	41.57%-1.89M	-18.60%-3.83M	-59.45%-12.03M	-74.58%-3.23M	-14.89%-7.54M	---1.85M	---6.57M
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Heat List

Overall

No Data